EFFICACY OF PROBIOTICS ON THE COGNITIVE FUNCTION, SLEEP EFFICIENCY, AND ANTIOXIDATIVE BIOMARKERS IN PATIENTS WITH ALZHEIMER'S DISEASE DEMENTIA: A 12-WEEK RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP CLINICAL TRIAL

被引：0
|
作者：
Sun, Y. [1 ,2 ]
Kuo, Y. -W. [3 ]
Tsai, S. -Y. [3 ]
Lin, J. -H. [3 ]
Hsu, Y. -C. [3 ]
Chen, J. -F. [3 ]
Hsia, K. -C. [3 ]
Ho, H. -H. [3 ]
Liu, H. -H. [4 ,5 ]
Kua, H. -C. [5 ]
机构：
[1] En Chu Kong Hosp, Neurol, New Taipei, Taiwan
[2] Natl Taiwan Univ, Coll Med, Neurol, Taipei, Taiwan
[3] Glac Biotech Co Ltd, Res & Design, Tainan, Taiwan
[4] Natl Hlth Res Inst, Mol & Genom Med, Zhunan Township, Miaoli County, Taiwan
[5] En Chu Kong Hosp, Pediat, New Taipei, Taiwan
来源：
SLEEP MEDICINE | 2024年 / 115卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：234 / 234
页数：1
相关论文
共 50 条
  • [21] Efficacy of ziprasidone monotherapy in patients with anxious depression: A 12-week, randomized, double-blind, placebo-controlled, sequential-parallel comparison trial
    Heo, Jung-Yoon
    Jeon, Hong Jin
    Fava, Maurizio
    Mischoulon, David
    Baer, Lee
    Clam, Alisabet
    Doorley, James
    Pisoni, Angela
    Papakostas, George I.
    JOURNAL OF PSYCHIATRIC RESEARCH, 2015, 62 : 56 - 61
  • [22] Evaluation of the Efficacy of BI 425809 Pharmacotherapy in Patients with Schizophrenia Receiving Computerized Cognitive Training: Methodology for a Double-blind, Randomized, Parallel-group Trial
    Harvey, Philip D.
    Bowie, Christopher R.
    McDonald, Sean
    Podhorna, Jana
    CLINICAL DRUG INVESTIGATION, 2020, 40 (04) : 377 - 385
  • [23] Evaluation of the Efficacy of BI 425809 Pharmacotherapy in Patients with Schizophrenia Receiving Computerized Cognitive Training: Methodology for a Double-blind, Randomized, Parallel-group Trial
    Philip D. Harvey
    Christopher R. Bowie
    Sean McDonald
    Jana Podhorna
    Clinical Drug Investigation, 2020, 40 : 377 - 385
  • [24] Augmenting Cognitive Function in the Elderly with Mild Cognitive Impairment Using Probiotic Lacticaseibacillus rhamnosus CBT-LR5: A 12-Week Randomized, Double-Blind, Parallel-Group Non-Comparative Study
    Jung, Su-Jin
    Cho, Kyohee
    Jung, Eun-Soo
    Son, Dooheon
    Byun, Jong-Seon
    Kim, Song-In
    Chae, Soo-Wan
    Yang, Jong-Chul
    Lee, Seung-Ok
    Lim, Sanghyun
    NUTRIENTS, 2025, 17 (04)
  • [25] Efficacy of ziprasidone monotherapy in patients with anxious depression: A 12-week, randomized, double-blind, placebo-controlled, sequential-parallel comparison trial
    Heo, Jung-Yoon
    Jeon, Hong Jin
    Fava, Maurizio
    Mischoulon, David
    Baer, Lee
    Clain, Alisabet
    Doorley, James
    Pisoni, Angela
    Papakostas, George I.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2016, 19 : 102 - 102
  • [26] Donepezil in patients with severe Alzheimer's disease:: double-blind, parallel-group, placebo-controlled study
    Winblad, B
    Kilander, L
    Eriksson, S
    Minthon, L
    Båtsman, S
    Wetterholm, AL
    Jarisson-Blixt, C
    Hoglund, A
    LANCET, 2006, 367 (9516): : 1057 - 1065
  • [27] Efficacy and safety of donepezil in patients with schizophrenia or schizoaffective disorder: A 12-week, randomized, double-blind, placebo-controlled trial
    Malhotra, AK
    Keefe, R
    Meltzer, H
    Kane, J
    Murthy, A
    Sovel, M
    Xu, YK
    Gold, L
    Goldman, R
    NEUROPSYCHOPHARMACOLOGY, 2004, 29 : S171 - S171
  • [28] Efficacy and Tolerability of Atorvastatin/Fenofibrate Fixed-Dose Combination Tablet Compared With Atorvastatin and Fenofibrate Monotherapies in Patients With Dyslipidemia: A 12-Week, Multicenter, Double-Blind, Randomized, Parallel-Group Study
    Davidson, Michael H.
    Rooney, Michael W.
    Drucker, Joan
    Griffin, H. Eugene
    Oosman, Sonia
    Beckert, Michael
    CLINICAL THERAPEUTICS, 2009, 31 (12) : 2824 - 2838
  • [29] A 36-week multicenter, randomized, double-blind, placebo-controlled,parallel-group, Phase 3 clinical trial of sodium oligomannate for mild-to-moderate Alzheimer disease
    XIAO Shi-fu
    中国药理学与毒理学杂志, 2019, 33 (06) : 403 - 403
  • [30] Efficacy and tolerability profile of etoricoxib in patients with osteoarthritis: A randomized, double-blind, placebo and active-comparator controlled 12-week efficacy trial
    Leung, AT
    Malmstrom, K
    Gallacher, AE
    Sarembock, B
    Poor, G
    Beaulieu, A
    Castro, R
    Sanchez, M
    DeTora, LM
    Ng, J
    CURRENT MEDICAL RESEARCH AND OPINION, 2002, 18 (02) : 49 - 58
12345